Have you recently published a manuscript? Kindly share the details and relevant links so that we may publish them on our website:  icras.crism.qm@gmail.com


Buprenorphine/naloxone and methadone effectiveness for reducing craving in individuals with prescription opioid use disorder: Exploratory results from an open-label, pragmatic randomized controlled trial McAnulty, C., Bastien, G., Socias, E., Bruneau, J., Le Foll, B., Lim, R., Brissette, S., Ledjiar, O., Marsan, S., Talbot, A., Jutras-Aswad, D.

Patient Satisfaction With Standard Methadone and Flexible Buprenorphine/Naloxone Models of Care: Results From a Pragmatic Randomized Controlled Clinical Trial Hassan, A., Bozinoff, N., Jutras-Aswad, D., Socias, E., Stewart, S., Lim, R., Le Foll, B.

Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial Socias, E., Wood, E., Le Foll, B., Lim, R., Cheol Choi, J., Yin Mok, W., Bruneau, J., Rehm, J., Wild, C., Bozinoff, N., Hassan, A., Jutras-Aswad, D.

Flexible Buprenorphine/Naloxone Model of Care for Reducing Opioid Use in Individuals With Prescription-Type Opioid Use Disorder: An Open-Label, Pragmatic, Noninferiority Randomized Controlled Trial Jutras-Aswad, D., Le Foll, B., Ahamad, K., Lim, R., Bruneau, J., Fischer, B., Rehm, J., Wild, C., Wood, E., Brissette, S., Gagnon, L., Fikowski, J., Ledjiar, O., Masse, B., Socias, E.

Selective personality-targeted prevention of suicidal ideation in young adolescents: post hoc analysis of data collected in a cluster randomised controlled trial. Grummitt, L.R., Debenham, J., Kelly, E.V., Barrett, E.L., Champion, K.E., Conrod, P.J., Teesson, M., & Newton, N.C.

Multidimensional analysis of adult patients’ care trajectories before a first diagnosis of schizophrenia Vanasse, A., Courteau, J., Courteau, M., Roy, M., Stip, E., Fleury, M., Lesage, A., & Brodeur, S.

The impact of opioid agonist treatment on hospitalisations for injecting-related diseases among an opioid dependent population: A retrospective data linkage study. Colledge-Frisby, S., Jones, N., Larney, S., Peacock, A., Lewer, D., Brothers, T. D., Hickman, M., Farrell, M., & Degenhardt, L.

Overdose deaths and HIV infections among people who use drugs: shared determinants and integrated responses Touesnard, N., Brothers, T. D., Bonn, M., & Edelman, E. J.

Telehealth for people who inject drugs: An acceptable method of treatment but challenging to access Samuel Delisle-Reda, Julie Bruneau,et Valérie Martel-Laferrière

Moral Foundations Theory Among Autistic and Neurotypical Children Erin Elizabeth Dempsey, Chris Moore, Shannon A. Johnson, Sherry H. Stewart and Isabel M. Smith

Office-based Methadone Prescribing for Opioid Use Disorder: The Canadian Model Robert A Kleinman, Thomas D Brothers, Marlon Danilewitz, Anees Bahji

Harm reduction in tobacco control: where do we draw the line? Mohammed Al-Hamdani & Eden Manly

Switching of opioid agonist treatment modality during imprisonment: A novel marker for increased support need during and following release from prison MichaelCurtis, Justin Berk, Sarah Larney, Josiah D.Rich, Mark Stoové


Déploiement d’un algorithme de soins en réponse à la crise des opioïdes Annie Talbot, Rania Khemiri, Aïssata Sako, Luc Londei-Leduc, Christine Robin, Suzanne Marcotte, Guenièvre Therrien, Geneviève Goulet, Geneviève Beaudet Hillman, Christine Ouellette, Suzanne Brissette, Marcel Martin, Polina Titova, Pierre Lauzon

Exploring cannabidiol effects on inflammatory markers in individuals with cocaine use disorder: a randomized controlled trial
Florence Morissette, Violaine Mongeau-Pérusse, Elie Rizkallah, Paméla Thébault, Stéphanie Lepage, Suzanne Brissette, Julie Bruneau, Simon Dubreucq, Emmanuel Stip , Jean-François Cailhier, Didier Jutras-Aswad

Framing public health response to the opioid and overdose crisis: are there alternatives to cascade of care model? Stine Bordier Høj, Julie Bruneau, Matthew Hickman

Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection.
Andreea Adelina Artenie, Matthew Hickman, Peter Vickerman, Jack Stone, Jason Grebely, Julie Bruneau

Psychedelic use is associated with reduced daily opioid use among people who use illicit drugs in a Canadian setting.Elena Argento, M Eugenia Socias, Kanna Hayashi, JinCheol Choi, Lindsay Mackay, Devon Christie, M-J Milloy, Kora DeBeck

Co-exposure of cannabinoids with amphetamines and biological, behavioural and health outcomes: a scoping review of animal and human studies. Dimitri Daldegan-Bueno, Lucas O Maia, Michelle Glass, Didier Jutras-Aswad, Benedikt Fischer

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada. Dennis C. Wendt, Stéphanie Marsan, Daniel Parker, Karen E. Lizzy, et al.

Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada. Emmanuel Fortier, Stine Bordier Høj, Marie-Pierre Sylvestre, Andreea Adelina Artenie, Nanor Minoyan, Didier Jutras-Aswad, Jason Grebely et Julie Bruneau

Improving the regulation of medical cannabis in Canada to better serve pediatric patients.Richard J HuntsmanLauren E KellyJane AlcornJuan Pablo AppendinoRichard E BélangerBruce CrooksYaron FinkelsteinAndrea GilpinEvan LewisCatherine LitalienJulia JacobsCharlotte Moore-Hepburn, Timothy OberlanderS Rod RassekhAlexander E RepetskiMichael J RiederAlan ShackelfordHal SidenMichael SzafronGeert W ‘t JongRégis Vaillancourt.

Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study. Cayley Russell, Farihah Ali, Frishta Nafeh, Jürgen Rehm, Sean LeBlanc, Tara Elton-Marshall

Work-life balance as a personal responsibility: The impact on strategies for coping with interrole conflict, Journal of Occupational Science. Michel Perreault & Niamh Power


Corrigendum: Cognitive Function Impairments Linked to Alcohol and Cannabis Use During Adolescence: A Study of Gender Differences. Noorbakhsh, S., Afzali, M., Boers, E., & Conrod, P.

Substance Use Wellness Tool. Chen, S., Stuart, H.L., Krupa, T., Dobson, K.S., & Stewart, S.H.

Applicability of the four-factor personality vulnerability model for substance misuse in understanding gambling behaviour and gambling problems. Otis, E., Yakovenko, I., Sherry, S., Smith, M., Goldstein, A.L., Ellery, M., Loverock, A., Wild, T.C., Weilgart-Whitehead, B., & Stewart, S.

Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada. Wendt, D. C., Marsan, S., Parker, D., Lizzy, K. E., Roper, J., Mushquash, C., Venner, K. L., Lam, A., Swansburg, J., Worth, N., Sorlagas, N., Quach, T., Manoukian, K., Bernett, P., & Radin, S. M.

Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness? Tibbo, P., McKee, K.A., Meyer, J., Crocker, C., Aitchison, K., Lam, R., & Crockford, D.

Does how you use matter? The link between mode of use and cannabis-related risk. Swan, C., Ferro, M., & Thompson, K.

Changes in positive and negative peer influences and depressive symptoms from adolescence to young adulthood. Homel, J., Thompson, K., & Leadbeater, B.

Substance use disorders among youth with chronic physical illness. Luther, A.W., Reaume, S.V., Qadeer, R.A., Thompson, K., & Ferro, M.A

Understanding Steps and Challenges to Take-home Naloxone and Buprenorphine/naloxone Implementation in Québec Emergency Rooms: Suboxed Project. Talbot, A., Khemiri, R., Sako, A., Londei-Leduc, L., Robin, C., Marcotte, S., Therrien, G., Goulet, G., Beaudet-Hilman, G., Ouellette, C., Brissette, S., Martin, M., Titova, P. & Lauzon, P.

Impact of early use of long-acting injectable antipsychotics on psychotic relapses and hospitalizations in first-episode psychosis. Abdel-Baki, A., Medrano, S., Maranda, C., Ladouceur, M., Tahir, R., Stip, E., & Potvin, S.

Facing Confinement, the Comfort of WhatsApp Groups in Mental Health Communities. Stip, E., Mugaddam, F. A., & Amiri, L.

Self-isolation: A significant contributor to cannabis use during the COVID-19 pandemic. Bartel, S.J., Sherry, S., & Stewart, S.

Examining Subgroups of Depression and Alcohol Misuse in Emerging Adults During University: a Replication and Extension Study. Orui, K., Frohlich, J.R., Stewart, S.H., Sherry, S.B., & Keough, M.T.

 The Network Constellation of Personality and Substance Use: Evolution from Early to Late Adolescence. Afzali, M., Stewart, S., Séguin, J., & Conrod, P.

Developing and testing the effectiveness of a novel online integrated treatment for problem gambling and tobacco smoking: a protocol for an open-label randomized controlled trial. Bilevicius, E., Single, A., Baumgartner, C., Bui, V., Kempe, T., Schaub, M. P., Stewart, S. H., MacKillop, J., Hodgins, D. C., Wardell, J. D., O’Connor, R., Read, J., Hadjistavropoulos, H., Sundstrom, C., & Keough, M. T.

Knowledge Translation in a Community-Based Study of the Relations Among Violence Exposure, Post-traumatic Stress and Alcohol Misuse in Mi’kmaq Youth. Zahradnik, M., Stewart, S., Stevens, D., & Wekerle, C.

An Alcohol Abuse Early Intervention Approach with Mi’kmaq Adolescents. Mushquash, C.J., Comeau, M., & Stewart, S.

Building a Collaborative Understanding of Pathways to Adolescent Alcohol Misuse in a Mi’kmaq Community: A Process Paper. Zahradnik, M., Stevens, D., Stewart, S., Comeau, N., Wekerle, C., & Mushquash, C.J.

 Drinking to cope with the pandemic: The unique associations of COVID-19-related perceived threat and psychological distress to drinking behaviors in American men and women. Rodriguez, L.M., Litt, D.M., & Stewart, S.H.

Cognitive biases in individuals with psychotic-like experiences: A systematic review and a meta-analysis. Livet, A., Navarri, X., Potvin, S., & Conrod, P.J.

Violence and Cannabis Use: A Focused Review of a Forgotten Aspect in the Era of Liberalizing Cannabis. Dellazizzo, L., Potvin, S., Athanassiou, M., Dumais, A.

Acute effects of partial CB1 receptor agonists on cognition – A meta-analysis of human studies. Zhornitsky, S., Pelletier, J., Assaf, R., Giroux, S., & Potvin, S.

Persistent cannabis use as an independent risk factor for violent behaviors in patients with schizophrenia. Beaudoin, M., Potvin, S., Giguére, C., Discepola, S., & Dumais, A.

Association Between the Use of Cannabis and Physical Violence in Youths: A Meta-Analytical Investigation. Dellazizzo, L., Potvin, S., Dou, B.Y., Beaudoin, M.M., Luigi, M., Giguére, C., & Dumais, A.

Peripheral Endogenous Cannabinoid Levels Are Increased in Schizophrenia Patients Evaluated in a Psychiatric Emergency Setting. Potvin, S., Mahrouche, L., Assaf, R., Chicoine, M., Giguére, C., Furtos, A., & Godbout, R.

 Montreal Cross‐Training Program: The contribution of positional clarification activities to help bridge fragmented prevention and treatment services for co‐occurring disorders. Perreault, M., Milton, D., Alunni‐Menichini, K., Archambault, L., Perreault, N., Bertrand, K

M92.The Overlap Between Psychotic Symptoms, Substance Use, and Adversity History: a Systematic Review. Patterson, V.C., Pencer, A.H., & Tibbo, P.G.

 The Effects of Alcohol and Depressive Symptoms on Positive and Negative Post-Event Rumination in Social Anxiety. Hagen, A.E., Battista, S.R., Couture, M., Pencer, A.H., & Stewart, S.H.

A Systematic Review of the Relative Frequency and Risk Factors for Prolonged Opioid Prescription Following Surgery and Trauma Among Adults. Pagé, M.G., Kudrina, I., Zomahoun, H.T., Croteau, J., Ziegler, D., Ngangue, P.A., Martín, E.A., Fortier, M., Boisvert, E.E., Beaulieu, P., Charbonneau, C., Cogan, J., Daoust, R., Martel, M.O., Néron, A., Richebe, P., & Clarke, H.A.

Relationships on the rocks: A meta-analysis of romantic partner effects on alcohol use. Muyingo, L., Smith, M.M., Sherry, S.B., McEachern, E., Leonard, K.E., & Stewart, S.H.

Challenging CBD protective effect against THC-related outcomes: a call for robust clinical trials. Mongeau-Pérusse, V., & Jutras-Aswad, D

Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs. Minoyan, N., Artenie, A., Zang, G., Jutras-Aswad, D., Turcotte, M., & Bruneau, J.

Epidemiology, Microbiology, and Clinical Outcomes Among Patients with Intravenous Drug Use-Associated Infective Endocarditis in New Brunswick. Mosseler, K., Materniak, S., & Webster, D.

Differences among hepatitis C patients seen in community and specialist outpatient care settings. Materniak, S., Bland, S., Margeson, A., Webster, D., Smyth, D., & O’Brien, M.

Risks of hepatitis C virus reactivation in a real-life population of oncology patients treated in an academic center. Boutin, C., Adam, J., Martel, D., Doucet, S., & Martel-Laferrière, V.

French-Canadian translation of a self-report questionnaire to monitor opioid therapy for chronic pain: The Opioid Compliance Checklist (OCC-FC). Poirier, C., Martel, M., Bérubé, M., Boulanger, A., Gélinas, C., Guénette, L., Lacasse, A., Lussier, D., Tousignant-Laflamme, Y., & Pagé, M.

The relative contribution of pain and psychological factors to opioid misuse: A 6-month observational study. Martel, M., Edwards, R., & Jamison, R.

Differences between women and men in the relationship between psychosocial stressors at work and work absence due to mental health problem.  Gilbert-Ouimet, M., Trudel, X., Aubé, K., Ndjaboue, R., Duchaine, C., Blanchette, C., Mâsse, B., Vézina, M., Milot, A., & Brisson, C

“Remote Monitoring of Intranasal Ketamine Self-Administration as Maintenance Therapy in Treatment-Resistant Depression (TRD): A Novel Strategy for Vulnerable and At-Risk Populations to COVID-19?”.  Longpré-Poirier, C., Jodoin, V.D., Miron, J., & Lespérance, P.

Global opioid agonist treatment: A review of clinical practices by country. Jin, H., Larney, S., Marshall, B.D., Degenhardt, L., Strang, J., Hickman, M., Fiellin, D.A., Ali, R., & Bruneau, J.

The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas. Warfield, S.C., Pack, R., Degenhardt, L., Larney, S., Bharat, C., Ashrafioun, L., Marshall, B.D., & Bossarte, R.

Association between opioid agonist therapy use and HIV testing uptake among people who have recently injected drugs: a systematic review and meta-analysis. Ferraro, C. F., Stewart, D. E., Grebely, J., Tran, L. T., Zhou, S., Puca, C., Hajarizadeh, B., Larney, S., Santo, T., Jr, Higgins, J., Vickerman, P., Degenhardt, L., Hickman, M., & French, C. E.

Risk of discharge against medical advice among hospital inpatients with a history of opioid agonist therapy in New South Wales, Australia: A cohort study and nested crossover-cohort analysis. Lewer, D., Jones, N. R., Hickman, M., Larney, S., Ezard, N., Nielsen, S., & Degenhardt, L.

Hospitalisations for non-fatal overdose among people with a history of opioid dependence in New South Wales, Australia, 2001-2018: Findings from the OATS retrospective cohort study. Jones, N. R., Hickman, M., Larney, S., Nielsen, S., Ali, R., Murphy, T., Dobbins, T., Fiellin, D. A., & Degenhardt, L.

Data resource profile: The Opioid Agonist Treatment and Safety (OATS) Study, New South Wales, Australia. Larney, S., Jones, N., Fiellin, D., Nielsen, S., Hickman, M., Dobbins, T., Murphy, T., Ali, R., & Degenhardt, L.

All-Cause and Overdose Mortality Risk Among People Prescribed Opioids: A Systematic Review and Meta-analysis. Larney, S., Peacock, A., Tran, L., Stockings, E., Santomauro, D., Santo, T., & Degenhardt, L.

Profile and correlates of injecting-related injuries and diseases among people who inject drugs in Australia. Colledge, S., Larney, S., Bruno, R., Gibbs, D., Degenhardt, L., Yuen, W.S., Dietze, P., & Peacock, A.

All-cause and cause-specific mortality among people with regular or problematic cocaine use: A systematic review and meta-analysis. Peacock, A., Tran, L., Larney, S., Stockings, E., Santo, T., Jones, H., Santomauro, D., & Degenhardt, L.

Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study. Nielsen, S., Picco, L., Kowalski, M., Sanfilippo, P., Wood, P., Larney, S., Bruno, R., & Ritter, A.

Feasibility and acceptability of take-home naloxone for people released from prison in New South Wales, Australia. Moradmand-Badie, B., Tran, L., Oikarainen, N., Degenhardt, L., Nielsen, S., Roberts, J., Ward, S., Bowman, J., & Larney, S.

Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: A systematic review and meta-analysis. Grebely, J., Tran, L., Degenhardt, L., Dowell-Day, A., Santo, T., Larney, S., Hickman, M., Vickerman, P., French, C., Butler, K., Gibbs, D., Valerio, H., Read, P., Dore, G., & Hajarizadeh, B.

What predicts pharmacists’ engagement with opioid-outcome screening? Secondary analysis from an implementation study in community pharmacy. Nielsen, S., Sanfilippo, P., Picco, L., Bruno, R., Kowalski, M., Wood, P., & Larney, S.

Injecting risk behaviours amongst people who inject drugs: A global multi-stage systematic review and meta-analysis. Tran, L.T., Peacock, A., Colledge, S., Memedovic, S., Grebely, J., Leung, J., Larney, S., Trickey, A., Stone, J., Vickerman, P., Hickman, M., & Degenhardt, L.

Self-Compassion as a Compensatory Resilience Factor for the Negative Emotional Outcomes of Alcohol- Involved Sexual Assault among Undergraduates. Strickland, N.J., Wekerle, C., Kehayes, I.L., Thompson, K., Dobson, K.S., & Stewart, S.H.

Emergency department-initiated interventions for patients with opioid use disorder: a systematic review. Kaczorowski, J., Bilodeau, J., Orkin, A.M., Dong, K.A., Daoust, R., & Kestler, A.

Discrete time measures versus trajectories of drinking frequency across adolescence as predictors of binge drinking in young adulthood: a longitudinal investigation. Sylvestre, M., Wellman, R., Ahun, M.N., Datta, G., Jutras-Aswad, D., & Loughlin, J.O.

 Assessing the current state of medical education on cannabis in Canada: Preliminary findings from Quebec. Elkrief, L., Belliveau, J., D’Ignazio, T., Simard, P., & Jutras-Aswad, D. 

Drug use during a pandemic: Convergent risk of novel coronavirus and invasive bacterial and viral infections among people who use drugs. Jacka, B., Phipps, E., & Marshall, B.D.

Experience of being a frequent user of primary care and emergency department services: a qualitative systematic review and thematic synthesis. Brodeur, M., Margo-Dermer, E., Chouinard, M., & Hudon, C.

Prolonged opioid use among opioid naïve individuals following prescription for non-specific low back pain in the emergency department. Hayden, J. A., Ellis, J., Asbridge, M., Ogilvie, R., Merdad, R., Grand, D. A. G., Stewart, S. A., & Campbell, S.

Psychological interventions for chronic non-specific low back pain: protocol of a systematic review with network meta-analysis. Ho, E., Ferreira, M., Chen, L., Simic, M., Ashton-James, C., Comachio, J., Hayden, J., & Ferreira, P.

Deconstructing the ‘cheque effect’: Short-term changes in injection drug use after receiving income assistance, and associated factors. Høj, S., Jacka, B., Minoyan, N., Bussière, P., & Bruneau, J.

Profiles of persons with current or previous experience of homelessness using emergency departments. Fleury, M., Grenier, G., Cao, Z., & L’espérance, N.

Typology of patients who use emergency departments for mental and substance use disorders. Fleury, M., Grenier, G., Bamvita, J., & Ferland, F.

Determinants of suicidal ideation and suicide attempt among former and currently homeless individuals. Gentil, L., Grenier, G., & Fleury, M.

Implementation of three innovative interventions in a psychiatric emergency department aimed at improving service use: a mixed-method study. Gabet, M., Grenier, G., Cao, Z., & Fleury, M.

Risk factors of hospitalization for any medical condition among patients with prior emergency department visits for mental health conditions. Penzenstadler, L., Gentil, L., Grenier, G., Khazaal, Y., & Fleury, M. 

Predictors of Frequent Emergency Department Utilization for Mental Health Reasons. Kaltsidis, G., Bamvita, J., Grenier, G., & Fleury, M.

Relationships Among Structures, Team Processes, and Outcomes for Service Users in Quebec Mental Health Service Networks. Fleury, M., Grenier, G., & Bamvita, J.

Prevalence, Characteristics, and Management of Chronic Noncancer Pain Among People Who Use Drugs: A Cross-Sectional Study. Kaboré, J., Dassieu, L., Roy, É., Jutras-Aswad, D., Bruneau, J., Pagé, M., & Choinière, M.

Predictors of Long‐Term Opioid Effectiveness in Patients With Chronic Non‐Cancer Pain Attending Multidisciplinary Pain Treatment Clinics: A Quebec Pain Registry Study. Kaboré, J., Saïdi, H., Dassieu, L., Choinière, M., & Pagé, M.

Management of psychosis in the context of cannabis use: Beyond the chicken or the egg question. Ouellet-Plamondon, C., Dubreucq, S., & Jutras-Aswad, D.

Opioid Poisoning and Opioid Use Disorder in Older Trauma Patients. Daoust, R., Paquet, J., Moore, L., Cournoyer, A., Émond, M., Gosselin, S., Lavigne, G., Boulanger, A., Mac-Thiong, J., & Chauny, J.

Pain, and not opioids, is associated with Delirium in older emergency department Patients. Daoust, R., & Paquet, J.

Another alternative to opioids for acute pain? Daoust, R.

Relationship between pain, opioid treatment, and delirium in older emergency department patients. Daoust, R., Paquet, J., Boucher, V., Pelletier, M.P., Gouin, E., & Émond, M.

Liver fibrosis in HIV-Hepatitis C virus (HCV) co-infection before and after sustained virologic response: what is the best non-invasive marker for monitoring regression? Kronfli, N., Young, J., Wang, S., Cox, J., Walmsley, S., Hull, M., Cooper, C., Martel-Laferrière, V., Wong, A., Pick, N., & Klein, M.

High-Risk Sexual Behavior, Binge Drinking and Use of Stimulants are Key Experiences on the Pathway to High Perceived HIV Risk Among Men Who Have Sex with Men in Brazil. Luz, P.M., Torres, T., Almeida-Brasil, C.C., Marins, L.M., Veloso, V., Grinsztejn, B., Cox, J., & Moodie, E.

Extraction of dried oral fluid spots (dofs) for the identification of drugs of abuse using liquid chromatography tandem mass spectrometry (lc-ms/ms). Gorziza, R.P., Cox, J., Limberger, R., & Arroyo, L.

Trends in hepatitis C virus seroprevalence and associated risk factors among men who have sex with men in Montréal: results from three cross-sectional studies (2005, 2009, 2018). Delaunay, C.L., Cox, J., Klein, M., Lambert, G., Grace, D., Lachowsky, N., & Maheu-Giroux, M.

The role of prison-based interventions for hepatitis C virus (HCV) micro-elimination among people who inject drugs in Montréal, Canada. Godin, A., Kronfli, N., Cox, J., Alary, M., & Maheu-Giroux, M.

Development, validation and evaluation of a quantitative method for the analysis of twenty-four new psychoactive substances in oral fluid by LC–MS/MS. Cooman, T., Santos, H., Cox, J., Filho, J.F., Borges, K.B., Romão, W., & Arroyo-Mora, L.E.

Predicting alcohol dependence from multi-site brain structural measures. Hahn, S., Mackey, S., Cousijn, J., …

Common and gender-specific associations with cocaine use on gray matter volume: Data from the ENIGMA addiction working group. Rabin, R.A., Mackey, S., Parvaz, M., …

Evaluating the differential effectiveness of social influence and personality-targeted alcohol prevention on mental health outcomes among high-risk youth: A novel cluster randomised controlled factorial design trial. Newton, N.C., Stapinski, L.A., Teesson, M., …

Heavy drinking in adolescents is associated with change in brainstem microstructure and reward sensitivity. Galinowski, A., Miranda, R., Lemaître, H., …

ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries. Thompson, P., Jahanshad, N., Ching, C., Salminen, L.E., …

Cognitive Function Impairments Linked to Alcohol and Cannabis Use During Adolescence: A Study of Gender Differences. Noorbakhsh, S., Afzali, M.H., Boers, E., & Conrod, P.J.

The IMAGEN study: a decade of imaging genetics in adolescents. Maričić, L.M., Walter, H., Rosenthal, A., …

The long-term effectiveness of universal, selective and combined prevention for alcohol use during adolescence: 36-month outcomes from a cluster randomized controlled trial. Slade, T., Newton, N.C., Mather, M., Barrett, E.L., Champion, K.E., Stapinski, L.A., Conrod, P.J., & Teesson, M.

How do substance use disorders compare to other psychiatric conditions on structural brain abnormalities? A cross-disorder meta-analytic comparison using the ENIGMA consortium findings. Navarri, X., Afzali, M.H., Lavoie, J., Sinha, R., …

A Dangerous “Cocktail”: The COVID-19 Pandemic and the Youth Opioid Crisis in North America: A Response to Vigo et al.  Jayasinha, R., Nairn, S., & Conrod, P.J. 

Teen vaping: There is no vapour without fire.  Chadi, N., & Bélanger, R.

Moving beyond perceived riskiness: Marijuana-related beliefs and marijuana use in adolescents Chadi, N., Levy, S., & Weitzman, E. R.

Cannabis vaping: Understanding the health risks of a rapidly emerging trend. Chadi, N., Minato, C., & Stanwick, R.

Underexplored Heterogeneity and Publication Bias for the Electronic Cigarette and Marijuana Use Association/Underexplored Heterogeneity and Publication Bias for the Electronic Cigarette and Marijuana Use Association-Reply. Wang, G., Wang, Yang, N., Chadi, N., & Levy, S.

Co-occurring Substance Use Disorders in Youth With Chronic Medical Conditions: The Need for Integration of Addiction Treatment into Mainstream Medical Facilities. Chadi, N. R., Schizer, M., Mountain-Ray, S., Thakur, A., Weitzman, E., & Levy, S.

Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study. Joudrey, P., Chadi, N., Roy, P., Morford, K., Bach, P., Kimmel, S., . . . Calcaterra, S.

Opening the door: inviting youth and parent perspectives on youth mental health emergency department use. Campbell, L., Lovas, D., Withers, E., & Peacock, K.

Exploring health-care providers’ experiences in the care of clients on opioid agonist treatment in two western Canadian clinics. Maina, G., Tahir, H., Docabo, A., Kahia, N., & Brunelle, C.

Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT). MacNeill, L., Brunelle, C., DiTommaso, E., & Skelding, B.

Experiences of Clients in Three Types of Methadone Maintenance Therapy in an Atlantic Canadian City: A Qualitative Study. MacNeill, L., Brunelle, C., Skelding, B., & DiTommaso, E.

Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Cochran, G., Bruneau, J., Cox, N., & Gordon, A.J.

Global opioid agonist treatment: A review of clinical practices by country. Jin, H., Marshall, B., Degenhardt, L., Strang, J., Hickman, M., Fiellin, D., …Bruneau, J., Larney, S.

Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study. Conway, B., Bruneau, J., Cooper, C., Steingart, C., Fraser, C., Stewart, K., Deshaies, L., Thomas, R., Webster, D., Macphail, G., Powis, J., Cox, J., Feld, J.J., McGovern, M.E., Trepanier, J.B., & Drolet, M.

Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic. Cochran, G., Bruneau, J., Cox, N., & Gordon, A. J.

Adherence to once-daily and twice-daily direct acting antiviral therapy for hepatitis C infection among people with recent injection drug use or current opioid agonist therapy. Cunningham, E., Hajarizadeh, B., Amin, J., Litwin, A., Gane, E., Cooper, C., Lacombe, K., Hellard, M., Read, P., Powis, J., Dalgard, O., Bruneau, J., Matthews., G., Feld, J., Dillon, J., Shaw, D., Bruggmann, P., Conway, B., Fraser, C., Marks, P., Dore, G., & Grebely, J.

Characterization of HCV-infected people who inject drugs (PWID) in the setting of clinical care in Canada (CAPICA): A retrospective study. Conway, B., Bruneau, J., Cooper, C., Steingart, C., Fraser, C., Stewart, K., Deshaies, L., Thomas, R., Webster, D., Macphail, G., Powis, J., Cox, J., Feld, J., McGovern, M.E., Trepanier, J., & Drolet, M.

Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada. Piske, M., Thomson, T., Krebs, E., Hongdilokkul, N., Bruneau, J., Greenland, S., Gustafson, P., Karim, M.E., McCandless, L., Maclure, M., Platt, R., Siebert, U., Socías, M.E., Tsui, J., Wood, E., & Nosyk, B.

Reinfection following successful direct-acting antiviral therapy for hepatitis C infection among people who inject drugs. Cunningham, E., Hajarizadeh, B., Amin, J., Hellard, M., Bruneau, J., Feld, J., Cooper, C., Powis, J., Litwin, A., Marks, P., Dalgard, O., Conway, B., Moriggia, A., Stedman, C., Read, P., Bruggmann, P., Lacombe, K., Dunlop, A., Applegate, T., Matthews., G., Fraser, C., Dore, G., & Grebely, J.

Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis. Cepeda, J.A., Vickerman, P., Bruneau, J., Zang, G., Bórquez, A., Farrell, M., Degenhardt, L., & Martin, N.

Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Hajarizadeh, B., Cunningham, Valerio, Martinello, Law, Janjua, . . . Bruneau, J., Grebely, J.

Sex Discrepancies in the Protective Effect of Opioid Agonist Therapy on Incident Hepatitis C Infection. Geddes, L., Iversen, J., Wand, H., Esmaeili, A., Tsui, J., Hellard, M., . . . Bruneau, J., Maher, L.

Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis. Cepeda, J., Vickerman, P., Bruneau, J., Zang, G., Borquez, A., Farrell, M., . . . Martin, N.

Harm Reduction for Women in Treatment for Alcohol Use Problems: Exploring the Impact of Dominant Addiction Discourse. Brown, C., & Stewart, S.

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply. Bonn, M., Palayew, A., Bartlett, S., Brothers, T. D., Touesnard, N., & Tyndall, M.

Challenges in Prediction, Diagnosis, and Treatment of Alcohol Withdrawal in Medically Ill Hospitalized Patients: A Teachable Moment. Brothers, T., & Bach, P.

Familial Attendance at Indian Residential School and Subsequent Involvement in the Child Welfare System Among Indigenous Adults Born During the Sixties Scoop Era. Bombay, A., McQuaid, R., Young, J., Sinha, V., Currie, V., Anisman, H., . . . St. Dennis, M.

Predictors of change in housing status over 12 months among individuals using emergency shelters, temporary housing or permanent housing in Quebec, Canada. Kaltsidis, G., Grenier, G., Cao, Z., Bertrand, K., & Fleury, M.

A critical scoping review about the impact of music in the lives of young adults who use drugs. Lemaire, E.C., Loignon, C., & Bertrand, K.

Current emergency response in Montreal: How does it fit in the services offered to homeless people who use substances? Alunni-Menichini, K., Roy, L., & Brousselle, A.

Avoiding the stigma. A qualitative study of socially included women’s experiences of drug use and dealing, health services and the police in France. Perrin, S., Bertrand, K., & Langlois, E.

Risk factors associated with developing anxiety in Inuit adolescents from Nunavik. Lamoureux-Tremblay, V., Muckle, G., Maheu, F., Jacobson, S. W., Jacobson, J. L., Ayotte, P.,Bélanger, R., . . . Saint-Amour, D.

How can primary care practitioners address substance use by adolescents? A position paper of the EUROPEAN academy of PAEDIATRICS. Michaud, P., Bélanger, R., Mazur, A., Hadjipanayis, A., & Ambresin, A.

A systematic review of technology-based psychotherapeutic interventions for decreasing cannabis use in patients with psychosis. Tatar, O., Bastien, G., Abdel-Baki, A., Huỳnh, C., Jutras-Aswad, D.

Non-pharmacological Considerations in Human Research of Nicotine and Tobacco Effects: A Review. Schlagintweit, H. E., Perry, R. N., Darredeau, C., Barrett, S.

The relative impact of acute nicotine and tobacco administration on craving, withdrawal, and cigarette self-administration in dependent and nondependent smokers Spinella, T.C., Barrett, S., & Schlagintweit, H.E.

Non-pharmacological Considerations in Human Research of Nicotine and Tobacco Effects: A Review Schlagintweit, H., Perry, R., Darredeau, C., & Barrett, S.

The generalizability of clinical and experimental tobacco research: Do exclusion criteria impact men and women differently? Spinella, T., Perry, R., Schlagintweit, H., & Barrett, S.

Prescription medication use as a risk factor for motor vehicle collisions: a responsibility study Asbridge, M., Macnabb, K., Chan, H., Erdelyi, S., Wilson, M.N., & Brubacher, J.

Cannabis-related driving and passenger behaviours among high school students: a cross-sectional study using survey data Carpino, M., Langille, D., Ilie, G., & Asbridge, M.

An experimental study on perceptions of energy drink ads among youth and young adults in Canada Wiggers, D., Asbridge, M., Baskerville, N., Reid, J., & Hammond, D.

Cannabis Packaging: An Opportunity for Facilitating Informed Decisions Al-Hamdani, M., Joyce, K.M., Park, T., Cowie, M.E., & Stewart, S.

Perceptions and Experiences of Vaping Among Youth and Young Adult E-Cigarette Users: Considering Age, Gender, and Tobacco Use Al-hamdani, M., Hopkins, D., Hardardottir, A., & Davidson, M.

Prolonged opioid use among opioid naïve individuals following prescription for non-specific low back pain in the emergency department Hayden JA, Ellis J, Asbridge M, Ogilvie R, Merdad R, Grant DAG, Stewart SA, Campbell S.

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply Bonn M, Palayew A, Bartlett S, Brothers T.D., Touesnard N, Tyndall M.

Emergency Department-Initiated Interventions for Patients With Opioid Use Disorder: A Systematic Review J Kaczorowski, J Bilodeau, A Orkin, K Dong, R Daoust, A Kestler


Impact of substance use and mental health comorbidity on health care access in Canada. G Dao, C Brunelle, D Speed

Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT). K MacNeill, C Brunelle, E DiTommaso, B Skelding

Effectiveness of Prescription Monitoring Programs in Reducing Opioid Prescribing, Dispensing, and Use Outcomes: A Systematic Review. MN Wilson, JA Hayden, E Rhodes, A Robinson, M Asbridge

The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review. E Rhodes, M Wilson, A Robinson, JA Hayden, M Asbridge

Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada. Fortier E, Sylvestre MP, Artenie A, Minoyan N, Jutras-Aswad D, Roy É, Grebelyg J, Bruneau J.

Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada. Jacka B, Larney S, Degenhardt L, Janjua N, Høj S, Krajden M, Grebely J, Bruneau J.

Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall B, Bruneau J, Altice F, Henderson G, Rahimi-Movaghar A, Larney S.

Strategies to reduce drug-related harm: responding to the evidence base. Degenhardt L, Wolfe D, Hall W, Hickman M, Chang J, Bruneau J, Farrell M, Griffiths P.

Specificity of personality relationships to particular forms of concurrent substance use among methadone maintenance therapy clients. Mahu IT, Conrod J, Barrett SP, Sako A, Swansburg J, Lawrence M, Laroque F, Morin JF, Chinneck A, Nogueira-Arjona R, Stewart SH.

Retrospective and prospective assessments of gambling-related behaviors across the female menstrual cycle. Joyce KM, Hudson A, O’Connor RM, Goldstein AL, Ellery M, McGrath DS, Perrot TS, Stewart SH.

Gambling Problem Trajectories and Associated Individuals Risk Factors: A Three-Year Follow-Up Study Among Poker Players. Dufour M, Morvannou A, Brunelle N, Kairouz S, Laverdière É, Nadeau L, Berbiche D, Roy É.

Dietary Sodium and the Health of Canadians. Campbell NRC, Bacon S, Pipe A, Grace SL, Arango M, Raine K, Kaczorowski J.

Mesolimbic connectivity signatures of impulsivity and BMI in early adolescence. Sharkey RJ, Bourque J, Larcher K, Mišić B, Zhang Y, Altınkaya A, Sadikot A, Conrod P, Evans AC, Garavan H, Leyton M, Séguin JR, Pihl R, Dagher A.

A Population-Based Analysis of the Relationship Between Substance Use and Adolescent Cognitive Development. Morin JG, Afzali MH, Bourque J, Stewart SH, Séguin JR, O’Leary-Barrett M, Conrod PJ.

Mega-Analysis of Gray Matter Volume in Substance Dependence: General and Substance-Specific Regional Effects. Mackey S, Allgaier N, Chaarani B, Spechler P, Orr C, Bunn J, Allen NB, Alia-Klein N, Batalla A, Blaine S, Brooks S, Caparelli E, Chye YY, Cousijn J, Dagher A, Desrivieres S, Feldstein-Ewing S, Foxe JJ, Goldstein RZ, Goudriaan AE, Heitzeg MM, Hester R, Hutchison K, Korucuoglu O, Li CR, London E, Lorenzetti V, Luijten M, Martin-Santos R, May A, Momenan R, Morales A, Paulus MP, Pearlson G, Rousseau ME, Salmeron BJ, Schluter R, Schmaal L, Schumann G, Sjoerds Z, Stein DJ, Stein EA1, Sinha R, Solowij N, Tapert S, Uhlmann A, Veltman D, van Holst R, Whittle S, Wright MJ, Yücel M, Zhang S, Yurgelun-Todd D, Hibar DP, Jahanshad N, Evans A, Thompson PM, Glahn DC, Conrod P, Garavan H; ENIGMA Addiction Working Group.

Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence. Orr C, Spechler P, Cao Z, Albaugh M, Chaarani B, Mackey S, D’Souza D, Allgaier N, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Burke Quinlan E, Conrod P, Desrivières S, Flor H, Frouin V, Gowland P, Heinz A, Ittermann B, Martinot JL, Martinot MP, Nees F, Papadopoulos Orfanos D, Paus T, Poustka L, Millenet S, Fröhner JH, Radhakrishnan R, Smolka MN, Walter H, Whelan R, Schumann G, Potter A, Garavan H.

A Review of Personality-Targeted Interventions for Prevention of Substance Misuse and Related Harm in Community Samples of Adolescents. Edalati H, Conrod PJ.

A Neuroethics Backbone for the Evolving Canadian Brain Research Strategy. Illes J, Weiss S, Bains J, Chandler JA, Conrod P, De Koninck Y, Fellows LK, Groetzinger D, Racine E, Robillard JM, Sokolowski MB.

How to help homeless youth suffering from first episode psychosis and substance use disorders? The creation of a new intensive outreach intervention team. Doré-Gauthier V, Côté H1, Jutras-Aswad D, Ouellet-Plamondon C, Abdel-Baki A.

Hepatitis C elimination among people who inject drugs: Challenges and recommendations for action within a health systems framework. Day E, Hellard M, Treloar C, Bruneau J, Martin NK, Øvrehus A, Dalgard O, Lloyd A, Dillon J, Hickman M, Byrne J, Litwin A, Maticic M, Bruggmann P, Midgard H, Norton B, Trooskin S, Lazarus JV, Grebely J; International Network on Hepatitis in Substance Users (INHSU).

The evolving drug epidemic of prescription opioid injection and its association with HCV transmission among people who inject drugs in Montréal, Canada. Bruneau J, Arruda N, Zang G, Jutras-Aswad D, Roy É.

Priorities and recommended actions for how researchers, practitioners, policy makers, and the affected community can work together to improve access to hepatitis C care for people who use drugs. Day E, Broder T, Bruneau J, Cruse S, Dickie M, Fish S, Grillon C, Luhmann N, Mason K, McLean E, Trooskin S, Treloar C, Grebely J.


Management of opioid use disorders: a national clinical practice guideline. Bruneau J, Ahamad K, Goyer ME, Poulin G, Selby P, Fischer B, Wild C, Wood E; on behalf of the CIHR CRISM

A prospective observational study of problematic oral cannabinoid use. Ware MA, Martel MO, Jovey R, Lynch ME, Singer J.

Association between binge drug use and suicide attempt among people who inject drugs. Fournier C, Ghabrash MF, Artenie A, Roy E, Zang G, Bruneau J, Jutras-Aswad D.

Associations between self-reported lifetime history of traumatic brain injuries and current disability assessment in a population sample of Canadian adults. Ilie G, Adlaf EM, Mann RE, Ialomiteanu A, Hamilton H, Rehm J, Asbridge M, Cusimano MD.

Changes in coping and social motives for drinking and alcohol consumption across the menstrual cycle. Joyce KM, Hudson A, O’Connor R, Thompson K, Hodgin M, Perrot T, Stewart SH.

Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence. Oviedo-Joekes E, Palis H, Guh D, Marchand K, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT.

Distinct pathological profiles of inmates showcasing cluster B personality traits, mental disorders and substance use regarding violent behaviors. Dellazizzo L, Dugré JR, Berwald M, Stafford MC, Côté G, Potvin S, Dumais A.

Does shyness interact with peer group affiliation in predicting substance use in adolescence? Lemyre A, Poliakova N, Vitaro F, Tremblay RE, Boivin M, Bélanger RE.

Drinking to cope with depression mediates the relationship between social avoidance and alcohol problems: A 3-wave, 18-month longitudinal study. Collins JL, Thompson K, Sherry SB, Glowacka M, Stewart SH.

Driving under the influence behaviours among high school students who mix alcohol with energy drinks. Wilson MN, Cumming T, Burkhalter R, Langille DB, Ogilvie R, Asbridge M.

Examining the Association Between Psychiatric Disorders and Cocaine Binges: Results From the COSMO Study. Juteau LC, Roy É, Berbiche D, Arruda N, Bruneau J, Jutras-Aswad D.

Formal and Informal Control of Cannabis: Regular Users’ Experience. Brochu S, Lépine P, Patenaude C, Erickson P.

High and escalating levels of cocaine intake are dissociable from subsequent incentive motivation for the drug in rats. Allain F, Bouayad-Gervais K, Samaha AN.

Impact of sex work on risk behaviours and their association with HIV positivity among people who inject drugs in Eastern Central Canada: cross-sectional results from an open cohort study. Campeau L, Blouin K, Leclerc P, Alary M, Morissette C, Blanchette C, Serhir B, Roy E; SurvUDI Working Group.

Mood-Induced Drinking in Coping with Anxiety-Motivated and Socially Motivated Drinkers: a Lab-Based Experiment Collins JL, Pencer A, Stewart SH.

Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta-analysis. Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, Maher L, Palmateer N, Taylor A, Bruneau J, Hickman M.

Sofosbuvir and velpatasvir for hepatitis C virus infection in people with recent injection drug use (SIMPLIFY): an open-label, single-arm, phase 4, multicentre trial. Grebely J, Dalgard O, Conway B, Cunningham EB, Bruggmann P, Hajarizadeh B, Amin J, Bruneau J, Hellard M, Litwin AH, Marks P, Quiene S, Siriragavan S, Applegate TL, Swan T, Byrne J, Lacalamita M, Dunlop A, Matthews GV, Powis J, Shaw D, Thurnheer MC, Weltman M, Kronborg I, Cooper C, Feld JJ, Fraser C, Dillon JF, Read P, Gane E24, Dore GJ; SIMPLIFY Study Group.


Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations. Fischer B, Russell C, Sabioni P, van den Brink W, Le Foll B, Hall W, Rehm J, Room R.

“I love having benzos after my coke shot”: The use of psychotropic medication among cocaine users in downtown Montreal. Motta-Ochoa R, Bertrand K, Arruda N, Jutras-Aswad D, Roy É.

A cluster-randomized controlled trial evaluating the effects of delaying onset of adolescent substance abuse on cognitive development and addiction following a selective, personality-targeted intervention programme: the Co-Venture trial. O’Leary-Barrett M, Mâsse B, Pihl RO, Stewart SH, Séguin JR, Conrod PJ.

A Qualitative Study of Addiction Help-Seeking in People with Different Co-occurring Mental Disorders and Substance Use Problems. Motta-Ochoa R, Bertrand K, Flores-Aranda J, Patenaude C, Brunelle N, Landry M, Brochu S.

A Review of CBT Treatments for Substance Use Disorders. Morin JF G, Harris M, Conrod PJ.

Addiction Severity and Suicidal Behaviors Among Persons Entering Treatment. Simoneau H, Ménard JM, Blanchette-Martin N.

Addiction severity index profile of persons who reenter treatment for substance use disorders. Simoneau H, Brochu S.

Adherence to response-guided pegylated interferon and ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: the ACTIVATE study. Cunningham EB, Hajarizadeh B, Dalgard O, Amin J, Hellard M, Foster GR, Bruggmann P, Conway B, Backmund M, Robaeys G, Swan T, Marks PS, Quiene S, Applegate TL, Weltman M, Shaw D, Dunlop A, Bruneau J, Midgard H, Bourgeois S, Thurnheer MC, Dore GJ, Grebely J; ACTIVATE Study Group.

Alcohol use among Inuit pregnant women: Validity of alcohol ascertainment measures over time. Fortin M, Muckle G, Jacobson SW, Jacobson JL, Bélanger RE.

An Investigation of the Association Between Shame and Problem Gambling: The Mediating Role of Maladaptive Coping Motives. Schlagintweit HE, Thompson K, Goldstein AL, Stewart SH.

Attentional bias toward alcohol-related stimuli in heavy drinkers: evidence from dynamic eye movement recording. Roy-Charland A, Plamondon A, Homeniuk AS, Flesch CA, Klein RM, Stewart SH.

Blunted ventral striatal responses to anticipated rewards foreshadow problematic drug use in novelty-seeking adolescents. Büchel C, Peters J, Banaschewski T, Bokde AL, Bromberg U, Conrod PJ, Flor H, Papadopoulos D, Garavan H, Gowland P, Heinz A, Walter H, Ittermann B, Mann K, Martinot JL, Paillère-Martinot ML, Nees F, Paus T, Pausova Z, Poustka L, Rietschel M, Robbins TW, Smolka MN, Gallinat J, Schumann G, Knutson B; IMAGEN consortium.

Cannabis and cue-induced craving in cocaine-dependent individuals: A pilot study. Giasson-Gariépy K, Potvin S, Ghabrash M, Bruneau J, Jutras-Aswad D.

Cannabis use and psychotic-like experiences trajectories during early adolescence: the coevolution and potential mediators. Bourque J, Afzali MH, O’Leary-Barrett M, Conrod PJ.

Changes in risk behaviours during and following treatment for hepatitis C virus infection among people who inject drugs: The ACTIVATE study. Midgard H, Hajarizadeh B, Cunningham EB, Conway B, Backmund M, Bruggmann P, Bruneau J, Bourgeois S, Dunlop A, Foster GR, Hellard M, Robaeys G, Thurnheer MC, Weltman M, Amin J, Marks PS, Quiene S, Dore GJ, Dalgard O, Grebely J; ACTIVATE Study Group.

Cocaine/crack use is not associated with fibrosis progression measured by AST-to-Platelet Ratio Index in HIV-HCV co-infected patients: a cohort study. Martel-Laferrière V, Nitulescu R, Cox J, Cooper C, Tyndall M, Rouleau D, Walmsley S, Wong L, Klein MB; Canadian Co-infection Cohort Study Investigators.

Contradictory advice for people who inject drugs in the 2016 EASL Recommendations on Treatment of Hepatitis C. Grebely J, Swan T, Hickman M, Bruneau J, Bruggmann P, Dalgard O, Litwin A, Backmund M, Dore GJ; International Network for Hepatitis in Substance Users.

Cross-training to work better together with women in Quebec who use substances: care providers’ perceptions. L’Espérance N, Bertrand K, Perreault M.

Depression, Anxiety, and Stress Among People With Chronic Hepatitis C Virus Infection and a History of Injecting Drug Use in New South Wales, Australia. Fortier E, Alavi M, Bruneau J, Micallef M, Perram J, Sockalingam S, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ, Grebely J; ETHOS Study Group.

Diversity in the Needs and Outcomes of Low-Threshold/High-Tolerance Methadone Maintenance Therapy Clients. Morrison K, Brunelle C, Campbell MA, Christie T, Hildebrand J.

Do romantic partners influence each other’s heavy episodic drinking? Support for the partner influence hypothesis in a three-year longitudinal study. Bartel SJ, Sherry SB, Molnar DS, Mushquash AR, Leonard KE, Flett GL, Stewart SH.

Drug use practices among people who inject drugs in a context of drug market changes: Challenges for optimal coverage of harm reduction programs. Roy É, Arruda N, Leclerc P, Morissette C, Blanchette C, Blouin K, Alary M.

Early Cannabis Use Initiation at 12–14 Years Old Associated With Thinner Frontal and Temporal Cortical Thickness. Laroque F, Bourque J, Spinney S,Sharkey R, Baker T, Dagher A, Garavan H, Leyton M, Seguin J, Pihl R, Conrod PJ.

Effectiveness of a selective alcohol prevention program targeting personality risk factors: Results of interaction analyses. Lammers J, Goossens F, Conrod P, Engels R, Wiers RW, Kleinjan M.

Effects of prenatal alcohol exposure in a prospective sample of young adults: Mental health, substance use, and difficulties with the legal system. Lynch MD, Kable JA, Coles CD.

Efficacy of extensive intervention models for substance use disorders: A systematic review. Simoneau H, Kamgang E, Tremblay J, Bertrand K, Brochu S, Fleury MJ.

Efficacy of response-guided directly observed pegylated interferon and self-administered ribavirin for people who inject drugs with hepatitis C virus genotype 2/3 infection: The ACTIVATE study. Grebely J, Dalgard O, Cunningham EB, Hajarizadeh B, Foster GR, Bruggmann P, Conway B, Backmund M, Robaeys G, Swan T, Amin J, Marks PS, Quiene S, Applegate TL, Weltman M, Shaw D, Dunlop A, Hellard M, Bruneau J, Midgard H, Bourgeois S, Staehelin C, Dore GJ; ACTIVATE Study Group.

Elimination of hepatitis C virus infection among PWID: The beginning of a new era of interferon-free DAA therapy. Grebely J, Bruneau J, Bruggmann P, Harris M, Hickman M, Rhodes T, Treloar C; International Network on Hepatitis in Substance Users6; International Network on Hepatitis in Substance Users.

Enduring changes in brain metabolites and executive functioning in abstinent cocaine users. Crocker CE, Purdon SE, Hanstock CC, Lakusta B, Seres P, Tibbo PG.

Estimates are not enough: scaling-up interventions to improve the health of people who inject drugs. Prins M, Bruneau J.

Estimating the harms and costs of cannabis-attributable collisions in the Canadian provinces. Wettlaufer A, Florica RO, Asbridge M, Beirness D, Brubacher J, Callaghan R, Fischer B, Gmel G, Imtiaz S, Mann RE, McKiernan A, Rehm J.

Examining the link between cocaine binging and individual, social and behavioral factors among street-based cocaine users. Roy É, Arruda N, Jutras-Aswad D, Berbiche D, Perreault M, Bertrand K, Dufour M, Bruneau J.

Experiences of peer-trainers in a take-home naloxone program: Results from a qualitative study. Marshall C, Perreault M, Archambault L, Milton D.

Exploring the psychological benefits and challenges experienced by peer-helpers participating in take-home naloxone programmes: A rapid review. Marshall C, Piat M, Perreault M.

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration. Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K; International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3).

Harm reduction in name, but not substance: a comparative analysis of current Canadian provincial and territorial policy frameworks. Hyshka E, Anderson-Baron J, Karekezi K, Belle-Isle L, Elliott R, Pauly B, Strike C, Asbridge M, Dell C, McBride K, Hathaway A, Wild TC.

High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention. Puzhko S, Roy É, Jutras-Aswad D, Artenie AA, Fortier E, Zang G, Bruneau J.

Initiation of Addiction Treatment and Access to Services: Young Adults’ Accounts of Their Help-Seeking Experiences. Wagner V, Bertrand K, Flores-Aranda J, Acier D, Brunelle N, Landry M, Brochu S.

Injection Drug Use, Unemployment, and Severe Food Insecurity Among HIV-HCV Co-Infected Individuals: A Mediation Analysis. McLinden T, Moodie E, Hamelin AM, Harper S, Walmsley S, Paradis G, Aibibula W, Klein M, Cox J.

Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis. Socías ME, Kerr T, Wood E, Dong H, Lake S, Hayashi K, DeBeck K, Jutras-Aswad D, Montaner J, Milloy MJ.

Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Lodhi RJ, Wang Y, Rossolatos D, MacIntyre G, Bowker A, Crocker C, Ren H, Dimitrijevic A, Bugbee DA, Loverock A, Majeau B, Sivapalan S, Newton VM, Tibbo P, Purdon SE, Aitchison KJ.

Is Personality Associated with Secondhand Harm from Drinking? Davis MacNevin P, Thompson K, Teehan M, Stuart H, Stewart S.

Men’s and women’s response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder. Palis H, Marchand K, Guh D, Brissette S, Lock K, MacDonald S, Harrison S, Anis AH, Krausz M, Marsh DC, Schechter MT, Oviedo-Joekes E.

Opioid Prescribing Practices and Training Needs of Québec Family Physicians for Chronic Noncancer Pain. Roy É, Côté RJ, Hamel D, Dubé PA, Langlois É, Labesse ME, Thibault C, Boulanger A.

Reversing the Atypical Valuation of Drug and Nondrug Rewards in Smokers Using Multimodal Neuroimaging. Baker TE, Lesperance P, Tucholka A, Potvin S, Larcher K, Zhang Y, Jutras-Aswad D, Conrod P.

Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection. Artenie AA, Zang G, Daniel M, Fortier E, Jutras-Aswad D, Puzhko S, Bruneau J.

Some PWID communities are ready for PrEP, so what’s next? Bruneau J, Roy É, Demers N, Cox J.

The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study. Cousien A, Leclerc P, Morissette C, Bruneau J, Roy É, Tran VC, Yazdanpanah Y, Cox J.

Understanding experiences of and rationales for sharing crack-smoking equipment: A qualitative study with persons who smoke crack in Montréal. Poliquin H, Bertrand K, Flores-Aranda J, Roy É.

Start typing and press Enter to search